IEQ Capital’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.65M Buy
98,060
+29,882
+44% +$576K 0.01% 876
2026
Q2
$1.25M Sell
68,178
-37,371
-35% -$799K 0.01% 1010
2026
Q1
$2.13M Buy
105,549
+1,195
+1% +$26.6K 0.01% 744
2025
Q4
$2M Sell
104,354
-17,033
-14% -$358K 0.01% 788
2025
Q3
$2.92M Sell
121,387
-2,928
-2% -$68.4K 0.01% 634
2025
Q2
$2.42M Buy
124,315
+103,853
+508% +$1.54M 0.01% 597
2025
Q1
$263K Buy
+20,462
New +$329K ﹤0.01% 1238

Other funds holding ADNT

IEQ Capital's ADNT Position: Q3 2026 in Review

IEQ Capital increased its Adient (ADNT) stake by 44% in Q3 2026, buying an estimated $576K and bringing the position to 98,060 shares worth $1.65M. The position accounts for 0.01% of the portfolio, ranked #876.

IEQ Capital first reported a position in ADNT in Q1 2025 and has held it in 7 quarters since. The position peaked at $2.92M in Q3 2025. 304 funds tracked by Wall St. Rank hold ADNT as of Q3 2026.

  • IEQ Capital held 98,060 shares of Adient worth $1.65M as of Q3 2026.
  • IEQ Capital bought 29,882 Adient shares in Q3 2026, an estimated $576K.
  • Adient made up 0.01% of IEQ Capital's portfolio in Q3 2026, its #876 holding.
  • IEQ Capital first reported a position in Adient in Q1 2025 and has held it in 7 quarters since.
  • IEQ Capital's Adient position peaked at $2.92M in Q3 2025.
  • 304 funds tracked by Wall St. Rank held Adient as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.